Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - INSMED Incex99_1.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
 
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported): June 4, 2012

INSMED INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)
 
Virginia
(State or Other Jurisdiction of Incorporation)
 
0-30739
 
54-1972729
(Commission File Number)
 
(IRS Employer Identification No.)
 
9 Deer Park Drive, Suite C, Monmouth Junction, NJ
 
08852
(Address of Principal Executive Offices)
 
(Zip Code)
 
(732) 997-4600
(Registrant’s Telephone Number, Including Area Code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 
 
INFORMATION TO BE INCLUDED IN THE REPORT
 
Item 7.01
Regulation FD Disclosure.
 
In June 2012, Insmed Incorporated updated the Company’s Investor Presentation. Our Chief Executive Officer and President, Timothy Whitten will present some or all of the June 2012 Investor Presentation to various investors in the coming months. A copy of the presentation materials is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
 
Item 9.01
Financial Statements and Exhibits
 
(d)
Exhibits
 
Exhibit No.
Description
 
99.1
June 2012 Investor Presentation
 
 
 

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Insmed Incorporated
 
Date: June 4, 2012
 
By: /s/ Kevin P. Tully, C.G.A.
Name: Kevin P. Tully, C.G.A.
Title: Executive Vice President & Chief Financial Officer
 
 
 

 

EXHIBIT INDEX
 
Exhibit No.
Description
 
June 2012 Investor Presentation